ACI Formulations PLC announcements
278 Dhaka Stock Exchange announcements for ACI Formulations PLC (ACIFORMULA) since 2008: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2023 (22).
- The Company has informed that the Board of Directors of the company at its Board Meeting held on 26 November 2023 decide
The Company has informed that the Board of Directors of the company at its Board Meeting held on 26 November 2023 decided to issue Sukuk instruments, of a size of up to BDT 600 crores under a long term fund-raising program via a special purpose vehicle to be formed by ACI Limited, ACI Formulations Limited, ACI Biotech Limited, ACI Chemicals Limited, ACI Edible Oils Limited, (cont.)
- (Continuation news of ACIFORMULA): ACI Foods Limited, ACI HealthCare Limited, ACI Logistics Limited, ACI Pure Flour Limi
(Continuation news of ACIFORMULA): ACI Foods Limited, ACI HealthCare Limited, ACI Logistics Limited, ACI Pure Flour Limited and ACI Salt Limited subject to receiving approval from the Bangladesh Securities and Exchange Commission (BSEC). (end)
The first part of this announcement is missing from the archive. - Resumption after Record date
Trading of the shares of the company will resume on 19.11.2023.
- Suspension for Record date
Trading of the shares of the company will remain suspended on record date i.e., 16.11.2023.
- (Q1 Un-audited): Consolidated EPS was Tk. 1.64 for July-September 2023 as against Tk. 1.55 for July-September 2022; Cons
(Q1 Un-audited): Consolidated EPS was Tk. 1.64 for July-September 2023 as against Tk. 1.55 for July-September 2022; Consolidated NOCFPS was Tk. 3.86 for July-September 2023 as against Tk. (18.65) for July-September 2022. Consolidated NAV per share was Tk. 66.21 as on September 30, 2023 and Tk. 64.57 as on June 30, 2023. (cont.1)
- (Continuation news of ACIFORMULA): Reasons for deviation in EPS, NAVPS and NOCFPS: Consolidated revenue increased mainly
(Continuation news of ACIFORMULA): Reasons for deviation in EPS, NAVPS and NOCFPS: Consolidated revenue increased mainly due to higher sales in CC & PH, Contract Manufacturing business. Higher sales along with changes in product mix in CC & PH business, led to increase overall gross profit whereas overall operating expenses increased due to efficient and effective control over operating cost. (cont.2)
The first part of this announcement is missing from the archive. - Q1 Financials
(Continuation news of ACIFORMULA): However, despite having higher financing cost mainly due to higher interest rate and utilization of working capital in line with increased sales, higher GP and controlled operating cost led to consolidated profit after tax resulting in higher consolidated EPS and NAV per share. Consolidated NOCFPS increased due to liquidation of inventory and efficient working capital management. (end)
The first part of this announcement is missing from the archive. - Spot News
Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 14.11.2023 to 15.11.2023 and trading of the shares will remain suspended on record date i.e., 16.11.2023.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2023 at 2:45 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2023.
- Dividend Declaration
The Board of Directors has recommended 25% Cash Dividend for the year ended June 30, 2023. Date of AGM: 28.12.2023, Time: 10:00 AM, Venue: Digital Platform. Record Date: 16.11.2023. The Company has also reported Consolidated EPS of Tk. 4.97, Consolidated NAV per share of Tk. 64.57 and Consolidated NOCFPS of Tk. 0.24 for the year ended June 30, 2023 as against Tk. 5.14, Tk. 65.88 and Tk. 7.23 respectively for the year ended June 30, 2022.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (29.10.2023) following its corporate declaration. However, the floor price shall be applicable accordingly.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 26, 2023 at 2:45 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2023.
- Resignation and Appointment of Acting Company Secretary
The company has informed that the Board of Directors approved the resignation of the previous company secretary, Mr. Nayamul Hoque. The Board also decided that Mr. Mohammad Mostafizur Rahman will be the acting Company Secretary of the company until the new Company Secretary is appointed to this position.
- (Q3 Un-audited): Consolidated EPS was Tk. 1.33 for January-March 2023 as against Tk. 1.53 for January-March 2022; Consol
(Q3 Un-audited): Consolidated EPS was Tk. 1.33 for January-March 2023 as against Tk. 1.53 for January-March 2022; Consolidated EPS was Tk. 5.36 for July 2022-March 2023 as against Tk. 5.24 for July 2021-March 2022. Consolidated NOCFPS was Tk. (11.29) for July 2022-March 2023 as against Tk. 0.38 for July 2021-March 2022. Consolidated NAV per share was Tk. 68.74 as on March 31, 2023 and Tk. 65.88 as on June 30, 2022. (cont.)
- Q3 Financials
(Continuation news of ACIFORMULA): Reason for significant deviation in NOCFPS: NOCFPS has been decreased due to inventory build-up for upcoming months. (end)
The first part of this announcement is missing from the archive. - Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 30, 2023 at 2:45 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2023.
- (Q2 Un-audited): Consolidated EPS was Tk. 2.49 for October-December 2022 as against Tk. 2.59 for October-December 2021;
(Q2 Un-audited): Consolidated EPS was Tk. 2.49 for October-December 2022 as against Tk. 2.59 for October-December 2021; Consolidated EPS was Tk. 4.04 for July-December 2022 as against Tk. 3.71 for July-December 2021. Consolidated NOCFPS was Tk. (16.30) for July-December 2022 as against Tk. 0.22 for July-December 2021. Consolidated NAV per share was Tk. 67.41 as on December 31, 2022 and Tk. 65.88 as on June 30, 2022. (cont.1)
- (Continuation news of ACIFORMULA): Reasons for deviation in EPS, NAVPS and NOCFPS: Consolidated revenue increased mainly
(Continuation news of ACIFORMULA): Reasons for deviation in EPS, NAVPS and NOCFPS: Consolidated revenue increased mainly due to higher sales in CC&PH, Paint and contract manufacturing business. Despite having adverse impact of BDT depreciation against USD, higher sales along with changes in product mix, led to increase overall gross profit. On the other hand, overall operating expenses increased due to normal pay rise and containment of fixed and variable expenses. (cont.2)
The first part of this announcement is missing from the archive. - Q2 Financials
(Continuation news of ACIFORMULA): However, financing cost increased mainly due to higher interest rate and utilization of working capital. Increased sales, higher GP led to higher consolidated EPS and NAV per share. Consolidated NOCFPS decreased due to inventory build-up for upcoming 3rd quarter. (end)
The first part of this announcement is missing from the archive. - Dividend Disbursement
The Company has informed that it has disbursed the cash dividend for the year ended June 30, 2022 to the respective shareholders.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2023 at 2:45 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2022.
- Credit Rating Information and Services Limited (CRISL) has assigned rating of the Company as \"AA-\" in the long term an
Credit Rating Information and Services Limited (CRISL) has assigned rating of the Company as \"AA-\" in the long term and \"ST-3\" in the short term along with Stable outlook based on audited financials up to June 30, 2022, unaudited financial up to September 30, 2022 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.